These findings were confirmed in a meta-analysis of three randomized clinical trials (n = 2234) in which resmetirom significantly reduced hepatic fat by magnetic resonance imaging-proton density fat fraction (MRI-PDFF) with 80 mg (27.74% at 36-52 weeks and 30.92% at 12-16 weeks) and with 100 mg (36.05% and 36.89%
By Lana Pine | Published on January 23, 2025 4 min read A study of more than 350,000 patients and found that, overall, patients who were treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) did not have a significantly higher risk of thyroid cancer
GLP-1 Weight Loss Injections Medical weight loss options have changed significantly in recent years, offering safer, more effective treatments for long-term results
by Hannah Frye This tiny, portable wand feels great on the skin but provides less coverage than full-face LED masks
Colaboramos estrechamente con nuestros distribuidores para dotarlos de los recursos necesarios para el xito en sus respectivos mercados
Statements Data availability statement The raw data supporting the conclusion of this article will be made available by the authors, without undue reservation